###begin article-title 0
###xml 147 148 147 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
Genetic Variants Associated with Arsenic Susceptibility: Study of Purine Nucleoside Phosphorylase, Arsenic (+3) Methyltransferase, and Glutathione S-Transferase Omega Genes
###end article-title 0
###begin p 1
S.D.C. and P.G. contributed equally to this publication.
###end p 1
###begin p 2
The authors declare they have no competing financial interests.
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
###xml 295 298 295 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PNP</italic>
###xml 333 338 333 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">As3MT</italic>
###xml 353 354 353 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 376 381 376 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO1</italic>
###xml 397 402 397 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO2</italic>
###xml 405 408 405 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PNP</italic>
###xml 442 447 442 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">As3MT</italic>
###xml 507 512 507 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO1</italic>
###xml 517 522 517 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO2</italic>
Individual variability in arsenic metabolism may underlie individual susceptibility toward arsenic-induced skin lesions and skin cancer. Metabolism of arsenic proceeds through sequential reduction and oxidative methylation being mediated by the following genes: purine nucleoside phosphorylase (PNP), arsenic (+3) methyltransferase (As3MT), glutathione S-transferase omega 1 (GSTO1), and omega 2 (GSTO2). PNP functions as arsenate reductase; As3MT methylates inorganic arsenic and its metabolites; and both GSTO1 and GSTO2 reduce the metabolites. Alteration in functions of these gene products may lead to arsenic-specific disease manifestations.
###end p 4
###begin title 5
Objectives
###end title 5
###begin p 6
To find any probable association between arsenicism and the exonic single nucleotide polymorphisms (SNPs) of the above-mentioned arsenic-metabolizing genes, we screened all the exons in those genes in an arsenic-exposed population.
###end p 6
###begin title 7
Methods
###end title 7
###begin p 8
Using polymerase chain reaction restriction fragment length polymorphism analysis, we screened the exons in 25 cases (individuals with arsenic-induced skin lesions) and 25 controls (individuals without arsenic-induced skin lesions), both groups drinking similar arsenic-contaminated water. The exonic SNPs identified were further genotyped in a total of 428 genetically unrelated individuals (229 cases and 199 controls) for association study.
###end p 8
###begin title 9
Results
###end title 9
###begin p 10
###xml 28 46 28 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PNP, As3MT, GSTO1,</italic>
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO2</italic>
###xml 152 155 152 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PNP</italic>
Among four candidate genes, PNP, As3MT, GSTO1, and GSTO2, we found that distribution of three exonic polymorphisms, His20His, Gly51Ser, and Pro57Pro of PNP, was associated with arsenicism. Genotypes having the minor alleles were significantly overrepresented in the case group: odds ratio (OR) = 1.69 [95% confidence interval (CI), 1.08-2.66] for His20His; OR = 1.66 [95% CI, 1.04-2.64] for Gly51Ser; and OR = 1.67 [95% CI, 1.05-2.66] for Pro57Pro.
###end p 10
###begin title 11
Conclusions
###end title 11
###begin p 12
###xml 36 39 36 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PNP</italic>
The results indicate that the three PNP variants render individuals susceptible toward developing arsenic-induced skin lesions.
###end p 12
###begin p 13
###xml 491 514 491 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5-ehp0116-000501">Chakraborti et al. 2002</xref>
###xml 792 809 791 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14-ehp0116-000501">Frost et al. 2003</xref>
###xml 811 847 810 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33-ehp0116-000501">World Health Organization (WHO) 2004</xref>
###xml 1057 1064 1056 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 1093 1109 1092 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3-ehp0116-000501">Basu et al. 2004</xref>
###xml 1111 1129 1110 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17-ehp0116-000501">Guha Mazumder 2003</xref>
###xml 1411 1428 1410 1427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18-ehp0116-000501">Haque et al. 2003</xref>
###xml 1733 1788 1732 1787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21-ehp0116-000501">International Agency for Research on Cancer (IARC) 2004</xref>
###xml 402 408 <span type="species:ncbi:9606">people</span>
Arsenic is recognized as a potent environmental toxicant that causes severe health problems in populations chronically exposed to arsenic-contaminated drinking water. However, the disease manifestations often depend on individual genetic variability. Corroborative of this view, although more than 6 million individuals in West Bengal, India, are endemically exposed to inorganic arsenic, only 300,000 people show arsenic-induced skin lesions, the hallmark sign of chronic arsenic exposure (Chakraborti et al. 2002). This fact clearly elucidates that genetic variability plays a critical role in susceptibility toward arsenic toxicity. It is worthwhile to mention that in West Bengal, groundwater in 9 of 18 districts is contaminated with arsenic, far above the acceptable limit of 10 mug/L [Frost et al. 2003; World Health Organization (WHO) 2004]. Chronic arsenic exposure causes various skin manifestations that include keratosis on palms and soles, hypopigmentation, characteristic raindrop pigmentations on chest, back, and legs, and in extreme cases, in situ carcinoma or Bowen disease (Basu et al. 2004; Guha Mazumder 2003). These skin lesions generally develop with a latency period spanning more than 10 years from first exposure; however, the latency period may be as short as 6 months, depending on the concentration of arsenic in drinking water, volume of intake, and health and nutritional status (Haque et al. 2003). In addition to skin lesions, other clinical manifestations of chronic arsenicism include peripheral neuropathy, peripheral vascular diseases, respiratory problems, conjunctivitis, various reproductive abnormalities, and ultimately, malignancies in a number of organs including skin, lung, and bladder [International Agency for Research on Cancer (IARC) 2004]. Although it is well known that arsenic can cause cellular toxicity and carcinogenicity, the underlying mechanism is yet undefined. Our survey of the published literature (1992-2007) found that alterations in the arsenic metabolism pathway, recently termed "arsenic biotransformation," may actually explain the molecular mechanism of arsenicism.
###end p 13
###begin p 14
###xml 137 138 137 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</sup>
###xml 183 219 183 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27-ehp0116-000501">National Research Council (NRC) 1999</xref>
###xml 332 333 332 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</sup>
###xml 336 347 336 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31-ehp0116-000501">Vahter 2002</xref>
###xml 445 469 445 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26-ehp0116-000501">Naranmandura et al. 2006</xref>
###xml 503 523 503 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19-ehp0116-000501">Hayakawa et al. 2005</xref>
###xml 604 605 604 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</sup>
###xml 614 615 614 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</sup>
###xml 683 684 683 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</sup>
###xml 702 703 702 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 798 799 798 799 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</sup>
###xml 804 805 804 805 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</sup>
###xml 814 815 814 815 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</sup>
###xml 913 916 913 916 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">III</sup>
###xml 921 924 921 924 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">III</sup>
###xml 933 936 933 936 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">III</sup>
###xml 939 959 939 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13-ehp0116-000501">Engstr&#246;m et al. 2007</xref>
###xml 76 82 <span type="species:ncbi:9606">humans</span>
To date, two pathways have been proposed to elucidate arsenic metabolism in humans. The classical pathway suggests that once arsenate (AsV) enters the cell via phosphate transporter [National Research Council (NRC) 1999], it undergoes sequential reduction and oxidative methylation, with only one end product, dimethyl arsinate (DMAV) (Vahter 2002). The newly proposed alternative pathway suggests that arsenic either binds to certain proteins (Naranmandura et al. 2006) or conjugates with glutathione (Hayakawa et al. 2005), and subsequent methylation results into two end products: methyl arsonate (MMAV) and DMAV. In both pathways, purine nucleoside phosphorylase (PNP) reduces AsV, and glutathione S-transferase omega 1 (GSTO1) and omega 2 (GSTO2) reduce all the pentavalent arsenic species (AsV, MMAV, and DMAV). Conversely, arsenic (+3) methyltransferase (As3MT) methylates the trivalent arsenic species (AsIII, MMAIII, and DMAIII) (Engstrom et al. 2007).
###end p 14
###begin p 15
###xml 123 126 123 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PNP</italic>
###xml 128 133 128 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">As3MT</italic>
###xml 135 140 135 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO1</italic>
###xml 146 151 146 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO2</italic>
###xml 601 604 601 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PNP</italic>
###xml 838 852 838 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36-ehp0116-000501">Yu et al. 2003</xref>
###xml 995 1011 995 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35-ehp0116-000501">Wood et al. 2006</xref>
###xml 1016 1021 1016 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">As3MT</italic>
###xml 1104 1105 1104 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 1126 1131 1126 1131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO1</italic>
###xml 1148 1153 1148 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO2</italic>
###xml 1248 1253 1248 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO1</italic>
###xml 1393 1414 1393 1414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25-ehp0116-000501">Mukherjee et al. 2006</xref>
###xml 1524 1546 1524 1546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32-ehp0116-000501">Whitebread et al. 2003</xref>
###xml 1647 1652 1647 1652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO2</italic>
###xml 1654 1675 1654 1675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25-ehp0116-000501">Mukherjee et al. 2006</xref>
Given the roles of these enzymes in arsenic biotransformation, functionally relevant genetic polymorphisms of these genes (PNP, As3MT, GSTO1, and GSTO2) are likely to produce interindividual variations in arsenic metabolism and thus susceptibility toward arsenic toxicity. To identify the genetic variants, we performed detailed screening of exonic regions in arsenic-metabolizing genes. Information regarding all genes studied was obtained from our review of the Single Nucleotide Polymorphism database () and published literature, which suggests that six polymorphisms occur in the exonic region of PNP gene, containing six exons (accession no. NM_000270, location 14q11.2). Among these, one is located in the 5'UTR (rs17881206); three (His20His, Gly51Ser, Pro57Pro) in exon 2; one in exon 5 (Ala174Ala); and one in the 3'UTR (rs7785) (Yu et al. 2003). Several exonic single nucleotide polymorphisms (SNPs) are also reported (Arg173Trp, Met287Thr, Thr306Ile, Ile132Phe, Tyr135Asn, Gly140Ala) (Wood et al. 2006) in As3MT containing 11 exons (NM_020682, location 10q24). Two members from the glutathione S-transferase family, GSTO1 (NM_004832) and GSTO2 (NM_183239), mapped to chromosome 10q are 7.5 kb from each other and contain 6 exons each. In GSTO1, although six exonic SNPs (Cys32Tyr, Ala140Asp, -/AGG, Glu208Lys, Thr217Asn, Ala236Val) have been identified in various world populations (Mukherjee et al. 2006), there has been a single report of a Thr217Asn variant in the dbSNP but not yet reported in any population (Whitebread et al. 2003). Four nonsynonymous exonic SNPs (Val114Ile, Cys130Tyr, Asn142Asp, Leu158Ile) were also reported in GSTO2 (Mukherjee et al. 2006).
###end p 15
###begin p 16
Our goal in this study was to identify exonic SNPs in the above-mentioned arsenic-metabolizing genes in the arsenic-exposed population of West Bengal and to ascertain a possible association between any of the identified exonic SNPs and development of arsenic-induced skin lesions.
###end p 16
###begin title 17
Materials and Methods
###end title 17
###begin title 18
Study sites and subject selection
###end title 18
###begin p 19
###xml 174 195 174 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7-ehp0116-000501">Chowdhury et al. 2000</xref>
###xml 621 645 621 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9-ehp0116-000501">De Chaudhuri et al. 2006</xref>
###xml 647 664 647 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16-ehp0116-000501">Ghosh et al. 2006</xref>
###xml 666 670 666 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15-ehp0116-000501">2007</xref>
###xml 1491 1503 <span type="species:ncbi:9606">participants</span>
###xml 1556 1563 <span type="species:ncbi:4097">tobacco</span>
###xml 1964 1976 <span type="species:ncbi:9606">participants</span>
From previous survey reports, we selected three districts of West Bengal that were identified as the most arsenic-affected region at the level of ground-water contamination (Chowdhury et al. 2000). For our field survey, we chose several villages in the following three districts: North 24 Parganas (five villages from four administrative blocks designated as Gaighata, Habra, Deganga, and Baduria), Nadia (two villages from Haringhata block), and Murshidabad (three villages from Bhagabangola block I and Bhagabangola block II). The detailed procedure of field survey and sample collection has been described previously (De Chaudhuri et al. 2006; Ghosh et al. 2006, 2007). In the present study, we recruited a total of 428 genetically unrelated study subjects, including 229 cases and 199 controls. The inclusion criteria for cases were based on the presence of more than one characteristic skin lesion, the hallmark sign of arsenicism as diagnosed by dermatologists. For selection of controls, we recruited genetically unrelated individuals without arsenic-induced skin lesions from the same villages; preferentially, family members of the cases who were related by marriage so that the exposure level through drinking water was similar. During our epidemiologic survey, we carried out a detailed pedigree analysis for each proband, rejecting the selection of parent-offspring or siblings from the same family, to avoid genetic overmatching. We also took the detailed case reports of study participants, including age, sex, addiction (in the form of both tobacco smoking and chewing), occupation, food habits, source of drinking water, and medical history. Questionnaire-generated data revealed that these individuals were exposed to arsenic only through groundwater, as tube wells were the only source of drinking water in these villages; any possibility of arsenic consumption through seafood was also ruled out. We obtained informed consent from all the study participants prior to the collection of drinking water and other biological samples such as blood, urine, nail, and hair. The study protocols adhered to the tenets of the Declaration of Helsinki II (2000) and was approved by the Indian Institute of Chemical Biology Institutional Review Board.
###end p 19
###begin title 20
Arsenic exposure assessment
###end title 20
###begin p 21
###xml 443 461 443 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4-ehp0116-000501">Buchet et al. 1981</xref>
###xml 463 485 463 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6-ehp0116-000501">Chatterjee et al. 1995</xref>
###xml 487 502 487 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8-ehp0116-000501">Das et al. 1995</xref>
To assess the overall load of arsenic in the body, we estimated arsenic content in drinking water, nail, hair, and urine samples. As arsenic shows strong reactivity and therefore affinity toward thiol compounds, it preferentially accumulates in peripheral keratin-rich tissues such as skin, nail, and hair. The detailed description of arsenic estimation and pretreatment procedure of biological samples and water has been reported previously (Buchet et al. 1981; Chatterjee et al. 1995; Das et al. 1995). We used flow injection-hydride generation-atomic absorption spectrometry (FI-HG-AAS) to estimate arsenic content in different biological samples (urine, nail, and hair) and drinking water. A Model Analyst-700 spectrometer at our institute equipped with a Hewlett-Packard Vectra computer with GEM software (Hewlett-Packard, Houston, TX, USA) , and arsenic lamp (lamp current 380 mA) was used for this purpose.
###end p 21
###begin title 22
Genotyping
###end title 22
###begin p 23
###xml 325 338 325 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28-ehp0116-000501">Sambrook 1989</xref>
###xml 473 474 472 473 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1679 1684 1676 1681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO2</italic>
###xml 1829 1833 1826 1830 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MboI</italic>
Exon screening for all the genes was initially carried out in 25 cases and 25 controls to identify the exonic SNPs in our population. All identified polymorphisms in our population were further validated in 229 cases and 199 controls for association study. DNA extraction from blood was carried out using standard protocols (Sambrook 1989). To amplify the exonic regions, polymerase chain reaction (PCR) was performed in a 25-muL reaction volume using standard buffer, MgCl2 (1.5 muM), deoxyribonucleotides (200 muM), and Taq polymerase supplied by Life Technologies, Carlsbad, CA, USA) in an MJ Research PTL-225 thermocycler (GeneAmp-9700; Applied Biosystems, Foster City, CA, USA). The sequences of flanking primers (Clontec, Mountain View, CA, USA) for exons of all the genes are described in Supplemental Material, Table 1 (online at ). All PCR products were analyzed by agarose (1.5%) or polyacrylamide gel (6%) electrophoresis, stained with ethidium bromide, and photographed under ultraviolet light. Bidirectional sequencing was done in an ABI prism 3100 DNA sequencer (Applied Biosystems), using Big Dye Terminator, pre-treated with Exo-SAP (Amersham Life Sciences, Little Chalfont, Buckinghamshire, UK). Samples with ambiguous chromatograms, as well as those containing SNPs observed in only a single sample, were subjected to a second, independent round of amplification, followed by DNA sequencing. The sequence chromatograms obtained were analyzed with Chromas 2.32 (Technelysium Pty Ltd, Tewantin, Australia) and compared with the reference sequence for genotyping of respective amplicons [Supplemental Material Table 2 (online at )]. The single exonic SNP found in GSTO2 (Asn142Asp) was genotyped by PCR-restriction fragment length polymorphism (RFLP). The 182-bp PCR product containing Asn142Asp was digested with MboI restriction enzyme (New England BioLabs, Inc., Beverly, MA, USA), which cleaved the DNA fragment to 86- and 96-bp fragments if the polymorphism were present. Five per cent of those samples were further validated with DNA sequencing in a bidirectional manner.
###end p 23
###begin title 24
Statistical analysis
###end title 24
###begin p 25
###xml 25 26 25 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 538 539 538 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 576 579 576 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PNP</italic>
###xml 581 586 581 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">As3MT</italic>
###xml 588 594 588 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO1,</italic>
###xml 599 604 599 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO2</italic>
###xml 679 700 679 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29-ehp0116-000501">Schneider et al. 2000</xref>
###xml 735 736 735 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 736 737 736 737 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 806 818 806 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2-ehp0116-000501">Barrett 2005</xref>
We performed an unpaired t-test was performed to calculate statistically significant differences between cases and controls in continuous independent variables (e.g., age, arsenic content in water, urine, nail, hair) by using GraphPad InStat Software (Graphpad Software Inc., San Diego, CA, USA). A chi-square test was used to compare the distribution of sex and haplotypes between two groups. The risk of developing an arsenic-induced skin lesion was calculated as the odds ratio (OR) with a 95% confidence interval (CI), as well as the p-value for exonic SNPs identified in PNP, As3MT, GSTO1, and GSTO2. Extended haplotypes were calculated using the ARLEQUIN software package (Schneider et al. 2000), and linkage disequilibrium (LD; r2) was calculated using the Haploview software package, version 3.32 (Barrett 2005). We performed a chi-square test using proper contingency tables to check the overall variation of the haplotypes between cases and controls, followed by association of a specific haplotype (having all three minor alleles) against the combined haplotypes with arsenicism.
###end p 25
###begin title 26
Results
###end title 26
###begin p 27
###xml 76 83 76 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1-ehp0116-000501">Table 1</xref>
###xml 308 309 308 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 367 368 367 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 390 391 390 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 512 513 512 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 525 526 525 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 617 618 617 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 631 632 631 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 210 217 <span type="species:ncbi:4097">tobacco</span>
Descriptive characteristics of the total study population are summarized in Table 1. Age, sex, and sociodemographic characteristics are similar in case and control groups. With regard to addiction status (both tobacco smoking and chewing), we did not find any significant deviation between two study groups (p = 0.37), even after stratifying the population in males (p = 0.76) and females (p = 0.66). The difference in mean arsenic content in drinking water and urine between the two groups was not significant (p = 0.92 and p = 0.64). When arsenic content in nail and hair was compared, it was much higher in cases (p < 0.001 and p < 0.001, respectively) compared with that in the control group.
###end p 27
###begin p 28
###xml 382 385 382 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PNP</italic>
###xml 400 405 400 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">As3MT</italic>
###xml 438 443 438 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO1</italic>
###xml 462 467 462 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO2</italic>
###xml 576 579 576 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PNP</italic>
###xml 638 643 638 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">As3MT</italic>
###xml 679 684 679 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO1</italic>
###xml 725 730 725 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO2</italic>
###xml 801 804 801 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PNP</italic>
###xml 809 814 809 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO1</italic>
###xml 1039 1046 1039 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2-ehp0116-000501">Table 2</xref>
###xml 1223 1226 1223 1226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PNP</italic>
###xml 1396 1399 1396 1399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PNP</italic>
We screened the entire exonic portion of the four genes in 100 chromosomes (25 cases and 25 controls) to get an initial overview of the commonly occurring SNPs in our population. The minor allele frequencies (MAF) of each variant were also calculated [Supplemental Material, Table 2 (online at )]. We detected eight commonly occurring polymorphisms (His20His, Gly51Ser, Pro57Pro in PNP; Met287Thr in As3MT; Ala140Asp, -/AGG, Glu208Lys in GSTO1; and Asn142Asp in GSTO2) in this population, but other reported polymorphisms (rs17881206 at 5' UTR, rs7785 at 3' UTR, Ala174Ala in PNP; Arg173Trp, Thr306Ile, Ile132Phe, Tyr135Asn, Gly140Ala in As3MT; Ser86Cys, Thr217Asn, Ala236Val in GSTO1; and Val114Ile, Leu158Ile, Cys130Tyr in GSTO2) were monomorphic in our population. We identified some novel SNPs in PNP and GSTO1. We studied genotypic distribution for these eight commonly occurring SNPs in 229 cases and 199 controls and estimated the association of each of these polymorphisms with the risk of developing arsenic-induced skin lesions (Table 2). The OR between case and control groups was calculated designating the major allele in the homozygous state as referent genotype for all the SNPs. Results indicated that only PNP polymorphisms were associated with arsenicism. Genotypes carrying at least one minor allele (i.e., heterozygous and homozygous genotype for minor alleles) for all three PNP polymorphisms were significantly overrepresented in cases [OR = 1.69 (95% CI, 1.08-2.66) for codon 20; OR = 1.66 (95% CI, 1.04-2.64) for codon 51; and OR = 1.67 (95% CI,1.05-2.66) for codon 57]. The results thus suggest that these individuals carrying minor alleles, either in heterozygous or homozygous condition, are at risk of developing arsenic-induced skin lesions.
###end p 28
###begin p 29
###xml 23 26 23 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PNP</italic>
###xml 80 81 80 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 81 82 81 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 331 334 331 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PNP</italic>
###xml 409 416 409 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3-ehp0116-000501">Table 3</xref>
###xml 815 816 815 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1006 1007 1006 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1018 1025 1018 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3-ehp0116-000501">Table 3</xref>
Pairwise haplotypes of PNP polymorphisms and their corresponding LD measured as r2 values were estimated. The LD values were significant among all three paired loci in both the study groups (0.85 for codons 20 and 57; 0.85 for codons 20 and 51; and 0.98 for codons 51 and 57) (not shown). Extended haplotypes considering all three PNP loci were constructed in the following order: codon 20-codon 51-codon 57 (Table 3). It is evident from the haplotypic distribution that the haplotype having highest frequency is the one that contains the major alleles at the respective loci, that is, C-G-C, followed by T-A-T, T-G-C, and C-A-T. The other three haplotypes found showed distribution exclusive to either case or control. Overall, there was no significant variation of haplotype frequency between cases and controls (p = 0.17). However, the specific T-A-T haplotype (i.e., having the minor alleles in the respective loci), against all other haplotypes combined, was significantly associated with arsenicism (p = 0.048) (Table 3).
###end p 29
###begin title 30
Discussion
###end title 30
###begin p 31
###xml 779 782 779 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PNP</italic>
Understanding the detailed metabolic pathway of ingested arsenic is critical in defining the molecular mechanisms of arsenic toxicity and carcinogenicity. The toxic or carcinogenic potential of ingested arsenic depends on a subtle balance between various arsenical intermediates because of retention or excretion. In the present study, the intake and excretion of arsenic between cases and controls were similar, but cases showed significantly higher arsenic accumulation in nail and hair. This load, coupled with the genetic idiosyncrasies of the arsenic-metabolizing genes, determines whether a particular individual will be susceptible to arsenic toxicity. This study shows that of eight exonic polymorphisms studied in four arsenic-metabolizing genes, three polymorphisms of PNP were significantly associated with arsenicism. The following section is a detailed account of the exonic SNPs identified in our population, with special emphasis on their distribution bias among the cases and controls, if any.
###end p 31
###begin title 32
PNP
###end title 32
###begin p 33
###xml 352 368 352 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1-ehp0116-000501">Aust et al. 1992</xref>
###xml 370 390 370 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34-ehp0116-000501">Williams et al. 1987</xref>
###xml 744 760 744 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36-ehp0116-000501">Yu et al. (2003)</xref>
###xml 777 778 777 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 778 779 778 779 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 925 943 925 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24-ehp0116-000501">Meza et al. (2005)</xref>
###xml 1030 1033 1030 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PNP</italic>
The Gly51Ser polymorphism at codon 51 resides in the proximity of the phosphate or arsenate-binding region of PNP enzyme (residues 56-69). Therefore, the substitution at this position may create some structural modification affecting protein function. However, a functional assay with variants in a case with severe combined immunodeficiency syndrome (Aust et al. 1992; Williams et al. 1987) showed no drastic alteration in enzyme activity. However, the possibility of a conservative change of glycine (nonpolar, uncharged) to serine (polar) to modulate the susceptibility level of individuals exposed to this xenobiotic cannot be ruled out without proper functional assays with the arsenic-exposed individuals. Consistent with the findings of Yu et al. (2003), the strong LD (r2 > 80) between codon 20 and codon 57 loci with codon 51 (Gly51Ser) perhaps explains the association of these two synonymous SNPs with arsenicism. Meza et al. (2005), in his studies with the Mexican population, found no significant correlation between PNP polymorphisms and urinary arsenic metabolites.
###end p 33
###begin title 34
As3MT
###end title 34
###begin p 35
###xml 12 19 12 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 24 32 24 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 174 192 174 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11-ehp0116-000501">Drobna et al. 2005</xref>
###xml 194 198 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12-ehp0116-000501">2006</xref>
###xml 421 437 421 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35-ehp0116-000501">Wood et al. 2006</xref>
###xml 507 510 507 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Met</italic>
###xml 474 479 <span type="species:ncbi:9606">human</span>
###xml 700 705 <span type="species:ncbi:9606">human</span>
A number of in vivo and in vitro studies established that As3MT enzyme is indispensable for conversion of the arsenic metabolites to their corresponding methylated products (Drobna et al. 2005, 2006). In our study, screening of the entire coding region revealed only one exonic SNP (Met287Thr) in our population, with a heterozygosity of about 9%, similar to studies with African-American and white American populations (Wood et al. 2006). It should be pointed out that the human major allele at codon 287, Met, is actually the nonancestral allele and that 10 other primates studies encoded Thr at the corresponding position. It would be interesting to assess the basis of the allele flipping in the human and the functional alteration of the protein product with the variant allele, if any.
###end p 35
###begin title 36
###xml 6 9 6 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">and</italic>
GSTO1 and GSTO2
###end title 36
###begin p 37
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO1</italic>
###xml 198 203 198 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO1</italic>
###xml 451 476 451 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30-ehp0116-000501">Tanaka-Kagawa et al. 2003</xref>
###xml 589 610 589 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32-ehp0116-000501">Whitbread et al. 2003</xref>
###xml 807 828 807 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22-ehp0116-000501">Marahatta et al. 2006</xref>
###xml 962 982 962 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20-ehp0116-000501">Hirakawa et al. 2002</xref>
###xml 984 1005 984 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32-ehp0116-000501">Whitbread et al. 2003</xref>
###xml 1450 1469 1450 1469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23-ehp0116-000501">Marnell et al. 2003</xref>
Six polymorphisms in the GSTO1 gene (Ser86Cys, Ala140Asp, -/AGG, Glu208Lys, Thr217Asn, Ala236Val) have been reported in various ethnic groups of the world or cited in the databases. Our analysis of GSTO1 could identify only three SNPs (Ala140Asp, -/AGG, Glu208Lys) among them. Generally, GSTO1 exhibits higher thiol transferase activity than GST. Tanaka-Kagawa et al. suggested that Ala140Asp polymorphism reduces thiol transferase activity of GSTO1 (Tanaka-Kagawa et al. 2003); however, another study found no such difference in enzyme activity due to the presence of the variant allele (Whitbread et al. 2003). A study in a Taiwanese population identified a significant association between the Asp140 variant of the GSTO1 gene variant and hepatocellular carcinoma, cholangio-carcinoma, and breast cancer (Marahatta et al. 2006). In fact, the frequency of the variant allele of the Asp140 variant of the GSTO1 gene varies significantly among world populations (Hirakawa et al. 2002; Whitbread et al. 2003). The frequency of the Asp140 variant in our population was 0.13, close to that of the Chinese population, reflecting a similarity within the Asian populations. Two other SNPs identified in our population (-/AGG and Glu208Lys) are reported to be associated with an inability to process inorganic arsenic. The -/AGG polymorphism is caused by a three-base deletion at the exon-intron border of exon 4, which might have potential for missplicing (Marnell et al. 2003). However, we could not find any significant difference in the genotypic distribution of any of the exonic SNPs between cases and controls.
###end p 37
###begin p 38
###xml 261 282 261 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32-ehp0116-000501">Whitbread et al. 2003</xref>
###xml 433 454 433 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25-ehp0116-000501">Mukherjee et al. 2006</xref>
There is 64% amino acid identity of GSTO2 enzyme with GSTO1. The minor allele frequency of the only exonic SNP identified in our population, Asn142Asp, is closely similar (0.28) to the European Australians in Canberra and the Chinese population from Hong Kong (Whitbread et al. 2003). This 142Asp variant is the major allele among Bantu Africans in Durban, Caucasian-American, Han-Chinese-American, and Mexican-American populations (Mukherjee et al. 2006), thus raising speculation about any ethnicity-specific selection bias. However, we found no association between the distribution of 142Asp variant and arsenicism in our population.
###end p 38
###begin title 39
Conclusion
###end title 39
###begin p 40
###xml 432 435 432 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PNP</italic>
This study highlights that genetic variants of PNP, one of the important enzymes in arsenic metabolism, are associated with development of arsenic-induced skin lesions. The study also provides basal knowledge of commonly occurring genetic polymorphisms in the protein-coding region of important arsenic-metabolizing genes. We did not find significant association of exonic SNPs in arsenic-metabolizing genes with arsenicism, except PNP. However, the interplay among the genes may be crucial in modulating the arsenic biotransformation pathway, and even minor changes in their functions can be reflected at phenotypic level and hence, in disease manifestation. Detailed functional studies are required in arsenic-exposed populations to understand the mechanisms involved. In this respect, gene knockouts can be used to examine the alterations in resulting in arsenic reduction and methylation pattern and the toxicologic consequences.
###end p 40
###begin p 41
Supplemental Material is available online at
###end p 41
###begin p 42
We thank P. Majumder (Indian Statistical Institute, Kolkata) for his advice on improving the work.
###end p 42
###begin p 43
We thank the Council of Scientific and Industrial Research for awarding a Senior Research Fellowship to S.D.C. and P.G. and also for sanctioning the Mission Mode Project on Toxicogenomics (CMM-0003). We also thank the Fogarty International Training Program in collaboration with University of California, Berkeley, for providing training to S.D.C. and P.G.
###end p 43
###begin title 44
References
###end title 44
###begin article-title 45
###xml 37 44 <span type="species:ncbi:9606">patient</span>
Molecular analysis of mutations in a patient with purine nucleoside phosphorylase deficiency
###end article-title 45
###begin article-title 46
Haploview: Analysis and visualization of LD and haplotype maps
###end article-title 46
###begin article-title 47
Micronuclei as biomarkers of carcinogen exposure in populations exposed to arsenic through drinking water in West Bengal, India: a comparative study in three cell types
###end article-title 47
###begin article-title 48
###xml 146 149 <span type="species:ncbi:9606">man</span>
Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate or dimethylarsinate in man
###end article-title 48
###begin article-title 49
Arsenic calamity in the Indian subcontinent: what lessons have been learned?
###end article-title 49
###begin article-title 50
###xml 170 176 <span type="species:ncbi:9606">people</span>
Arsenic in ground water in six districts of West Bengal, India: the biggest arsenic calamity in the world. I. Arsenic species in drinking water and urine of the affected people
###end article-title 50
###begin article-title 51
Groundwater arsenic contamination in Bangladesh and West Bengal, India
###end article-title 51
###begin article-title 52
###xml 224 230 <span type="species:ncbi:9606">people</span>
Arsenic in groundwater in six districts of West Bengal, India: the biggest arsenic calamity in the world. II. Arsenic concentration in drinking water, hair, nails, urine, skin-scale and liver tissue (biopsy) of the affected people
###end article-title 52
###begin article-title 53
Association of specific p53 polymorphisms with keratosis in individuals exposed to arsenic through drinking water in West Bengal, India
###end article-title 53
###begin article-title 54
The World Medical Association Ethics Unit. Ferney-Voltaire
###end article-title 54
###begin article-title 55
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 72 75 <span type="species:ncbi:10116">rat</span>
Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferase
###end article-title 55
###begin article-title 56
shRNA silencing of AS3MT expression minimizes arsenic methylation capacity of HepG2 cells
###end article-title 56
###begin article-title 57
Genetic polymorphisms influencing arsenic metabolism: Evidence from Argentina
###end article-title 57
###begin article-title 58
Identifying US populations for the study of health effects related to drinking water arsenic
###end article-title 58
###begin article-title 59
Comparison of health effects between individuals with and without skin lesions in the population exposed to arsenic through drinking water in West Bengal, India
###end article-title 59
###begin article-title 60
Cytogenetic damage and genetic variants in the individuals susceptible to arsenic-induced cancer through drinking water
###end article-title 60
###begin article-title 61
Chronic arsenic toxicity: clinical features, epidemiology, and treatment: experience in West Bengal
###end article-title 61
###begin article-title 62
Arsenic in drinking water and skin lesions: dose-response data from West Bengal, India
###end article-title 62
###begin article-title 63
###xml 86 91 <span type="species:ncbi:9606">human</span>
A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19
###end article-title 63
###begin article-title 64
JSNP: a database of common gene variations in the Japanese population
###end article-title 64
###begin article-title 65
Some Drinking Water Disinfectants and Contaminants, Including Arsenic
###end article-title 65
###begin article-title 66
###xml 28 29 28 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
Polymorphism of glutathione S-transferase omega gene and risk of cancer
###end article-title 66
###begin article-title 67
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO1</italic>
###xml 21 26 <span type="species:ncbi:9606">human</span>
Polymorphisms in the human monomethylarsonic acid (MMA V) reductase/hGSTO1 gene and changes in urinary arsenic profiles
###end article-title 67
###begin article-title 68
###xml 128 133 128 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYT19</italic>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 151 159 <span type="species:ncbi:9606">children</span>
Developmentally restricted genetic determinants of human arsenic metabolism: association between urinary methylated arsenic and CYT19 polymorphisms in children
###end article-title 68
###begin article-title 69
###xml 12 13 12 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
Glutathione S-transferase omega 1 and omega 2 pharmacogenomics
###end article-title 69
###begin article-title 70
Trivalent arsenicals are bound to proteins during reductive methylation
###end article-title 70
###begin article-title 71
###xml 140 145 <span type="species:ncbi:9606">human</span>
Arsenite and arsenate activate extracellular signal-regulated kinases 1/2 by an epidermal growth factor receptor-mediated pathway in normal human keratinocytes
###end article-title 71
###begin article-title 72
Mechanisms of arsenic biotransformation
###end article-title 72
###begin article-title 73
###xml 24 29 <span type="species:ncbi:9606">human</span>
Characterization of the human Omega class glutathione transferase genes and associated polymorphisms
###end article-title 73
###begin article-title 74
###xml 2 7 <span type="species:ncbi:9606">human</span>
A human purine nucleoside phosphorylase deficiency caused by a single base change
###end article-title 74
###begin article-title 75
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human arsenic methyltransferase (AS3MT) pharmacogenetics: gene resequencing and functional genomics studies
###end article-title 75
###begin article-title 76
###xml 75 76 75 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
Genetic variation in genes associated with arsenic metabolism: glutathione S-transferase omega 1-1 and purine nucleoside phosphorylase polymorphisms in European and indigenous Americans
###end article-title 76
###begin p 77
###xml 41 53 <span type="species:ncbi:9606">participants</span>
Descriptive characteristics of the study participants.
###end p 77
###begin p 78
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 20 21 20 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
p < 0.001 [unpaired t-test (two-tailed)].
###end p 78
###begin p 79
###xml 19 22 19 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PNP</italic>
Risk assessment of PNP polymorphisms between cases and controls.
###end p 79
###begin p 80
###xml 6 7 6 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 15 16 15 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Case, n = 229; n = control, 199. Discrepancy in the number of genotyped data in some of the loci is due to PCR failure even after multiple independent efforts.
###end p 80
###begin p 81
Extended haplotype frequencies of the study population.
###end p 81
###begin p 82
###xml 58 59 58 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
T-A-T haplotype was found to be overrepresented in cases (p = 0.048).
###end p 82

